Evaluation and Management of Postmenopausal Bleeding
Postmenopausal bleeding requires urgent referral and evaluation as endometrial cancer is present in approximately 10% of cases, though most causes are benign. 1, 2
Initial Assessment
First-line evaluation:
- Transvaginal ultrasound (TVUS) combined with transabdominal ultrasound for anatomic overview
- Color and spectral Doppler to assess vascularity 1
Key endometrial thickness thresholds:
- ≤4 mm: No further evaluation needed if asymptomatic (negative predictive value for endometrial cancer nearly 100%) 1
4 mm: Further investigation required due to low specificity for pathological findings 3
- ≥8 mm: Hysteroscopy with directed biopsy recommended 1
- ≥10 mm: Histopathological testing strongly recommended (6.3% prevalence of endometrial malignancy) 1
11 mm: Risk estimate for endometrial cancer of 9.1% 1
Diagnostic Algorithm
If endometrial thickness ≤4 mm and bleeding has stopped:
- No further action needed 2
If endometrial thickness >4 mm or persistent bleeding:
If ultrasound is inconclusive or inadequate visualization:
- Consider saline infusion sonohysterography (SIS) or
- MRI pelvis without and with IV contrast 1
If suspicion of malignancy, abnormal findings on ultrasound, or persistent unexplained bleeding:
- CT abdomen and pelvis with IV contrast 1
For persistent or recurrent postmenopausal bleeding:
- Hysteroscopy with biopsy and/or resection is mandatory regardless of TVUS results 3
Risk Factors to Assess
- Obesity
- Diabetes mellitus
- Hypertension
- History of unopposed estrogen exposure
- Tamoxifen therapy
- Lynch syndrome (particularly MLH1 gene) 1
Special Considerations
Lynch syndrome patients: Consider hysterectomy with bilateral salpingo-oophorectomy starting at age 40 1
Post-hysterectomy vaginal bleeding: Requires thorough evaluation including:
- Transvaginal ultrasound
- Vaginal cytology
- Targeted biopsies
- Speculum examination 1
Patients with history of CIN2/3 or cervical cancer: Should undergo vaginal cytology as part of evaluation 1
Common Causes of Postmenopausal Bleeding
- Endometrial cancer (10% of cases)
- Endometrial hyperplasia with/without polyps
- Cervical polyps or carcinoma
- Vaginal atrophy
- Hormone-producing ovarian tumors
- Non-gynecologic sources (hematuria, rectal bleeding) 2, 4
Management Based on Findings
Endometrial hyperplasia: May be treated with cyclic progestogens to revert to normal endometrium 1
Vaginal atrophy: Consider local estrogen therapy if not contraindicated 1
For mild cramping/discomfort post-procedure: NSAIDs and pelvic rest until bleeding resolves 1
Follow-up: Visit within 1-2 weeks if bleeding persists; urgent evaluation if heavy bleeding, severe pain, or fever develops 1
Pitfalls to Avoid
Relying solely on endometrial biopsy: Remember the 10% false-negative rate; consider hysteroscopy for persistent symptoms 1
Overlooking non-gynecologic causes: Ensure thorough evaluation for urinary or gastrointestinal sources of bleeding 2
Missing rare causes: Unusual etiologies like malunited pelvic fractures can cause vaginal wall lacerations 5
Inadequate follow-up: Persistent or recurrent bleeding requires hysteroscopy regardless of initial TVUS findings 3